rs745508510
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_015599.3(PGM3):āc.965T>Cā(p.Ile322Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000441 in 1,587,184 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 32)
Exomes š: 0.0000042 ( 0 hom. )
Consequence
PGM3
NM_015599.3 missense
NM_015599.3 missense
Scores
2
9
8
Clinical Significance
Conservation
PhyloP100: 8.42
Genes affected
PGM3 (HGNC:8907): (phosphoglucomutase 3) This gene encodes a member of the phosphohexose mutase family. The encoded protein mediates both glycogen formation and utilization by catalyzing the interconversion of glucose-1-phosphate and glucose-6-phosphate. A non-synonymous single nucleotide polymorphism in this gene may play a role in resistance to diabetic nephropathy and neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-83178737-A-G is Pathogenic according to our data. Variant chr6-83178737-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 421723.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=2, Pathogenic=1, Likely_pathogenic=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PGM3 | NM_015599.3 | c.965T>C | p.Ile322Thr | missense_variant | 8/13 | ENST00000513973.6 | NP_056414.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PGM3 | ENST00000513973.6 | c.965T>C | p.Ile322Thr | missense_variant | 8/13 | 1 | NM_015599.3 | ENSP00000424874.1 | ||
PGM3 | ENST00000283977.9 | c.722T>C | p.Ile241Thr | missense_variant | 7/12 | 5 | ENSP00000283977.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152222Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152222
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251152Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135764
GnomAD3 exomes
AF:
AC:
3
AN:
251152
Hom.:
AF XY:
AC XY:
1
AN XY:
135764
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000418 AC: 6AN: 1434962Hom.: 0 Cov.: 26 AF XY: 0.00000419 AC XY: 3AN XY: 715754
GnomAD4 exome
AF:
AC:
6
AN:
1434962
Hom.:
Cov.:
26
AF XY:
AC XY:
3
AN XY:
715754
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74362
GnomAD4 genome
AF:
AC:
1
AN:
152222
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74362
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Immunodeficiency 23 Pathogenic:2Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 29, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 350 of the PGM3 protein (p.Ile350Thr). This variant is present in population databases (rs745508510, gnomAD 0.003%). This missense change has been observed in individual(s) with primary immunodeficiency without hyper-IgE levels (PMID: 26482871). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Ile322Thr. ClinVar contains an entry for this variant (Variation ID: 421723). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C45"). Experimental studies have shown that this missense change affects PGM3 function (PMID: 26482871). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Apr 20, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Dec 22, 2021 | PGM3 NM_001199917.1 exon 9 p.Ile350Thr (c.1049T>C): This variant has been reported in the literature (as p.Ile322Thr) as homozygous in 1 individual with recurrent infection, neutropenia and eosinophilia, segregating with disease in 1 affected family member (Bjorksten 1976 PMID:1245758, Lundin 2015 PMID:26482871). Of note, both unaffected parents and an unaffected sibling were identified to be heterozygous; two other siblings were also affected but did not receive genetic testing. This variant is present in 2/111592 European alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs745508510). This variant is present in ClinVar (Variation ID:421723). Evolutionary conservation and computational predictive tools for this variant are unclear. In vitro functional studies suggest that this variant destabilizes the protein (Lundin 2015 PMID:26482871). However, these studies may not accurately represent in vivo biological function. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 30, 2020 | - - |
Severe combined immunodeficiency disease Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 15, 2024 | Variant summary: PGM3 c.1049T>C (p.Ile350Thr) results in a non-conservative amino acid change located in the Phosphoacetylglucosamine mutase AMG1, domain III (IPR049022) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251152 control chromosomes. c.1049T>C has been reported in the literature in homozygous and compound heterozygous individuals affected with Severe Combined Immunodeficiency (Lundin_2015, Winslow_2022). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 480% of normal enzyme activity in an in vitro assay (Lundin_2015). The following publications have been ascertained in the context of this evaluation (PMID: 26482871, 35040011). ClinVar contains an entry for this variant (Variation ID: 421723). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 23, 2023 | Published functional studies demonstrate a damaging effect on enzyme activity (Ludin et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 1245758, 35040011, 26482871) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;T;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;.;M;.;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;.;D;D;D
REVEL
Benign
Sift
Uncertain
D;.;D;D;D
Sift4G
Uncertain
D;D;D;D;D
Polyphen
B;.;.;.;.
Vest4
MutPred
Loss of stability (P = 0.0047);.;Loss of stability (P = 0.0047);.;.;
MVP
MPC
0.36
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at